Science & Enterprise subscription

Follow us on Twitter

  • A new enterprise, spun off from Seattle Children’s Research Institute, is creating therapeutics for diseases from e… https://t.co/CvnMEFT0Cm
    about 8 hours ago
  • New post on Science and Enterprise: Start-Up Developing Engineered B-Cell Therapies https://t.co/vMgdwnIXdi #Science #Business
    about 8 hours ago
  • Global drug maker Roche Group is acquiring an experimental antiviral therapy for Covid-19 infections taken as a ora… https://t.co/e2d7m6HG1E
    about 12 hours ago
  • New post on Science and Enterprise: Roche Gains Covid-19 Oral Drug Candidate https://t.co/nh27g6uCwi #Science #Business
    about 12 hours ago
  • The day that America lost $100 billion because of an immigration visa ban https://t.co/OfEx6SFwxA via @BrookingsInst
    about 1 day ago

Please share Science & Enterprise

Process Tests Thousands of Covid-19 Samples at Once

Covid-19 testing

A new technology makes possible simultaneous analysis of diagnostic specimens from thousands of individuals revealing the presence of SARS-CoV-2 coronaviruses. . . . → Read More: Process Tests Thousands of Covid-19 Samples at Once

FDA Bucks White House, Issues Strict Vaccine Guidance

White House

The U.S. Food and Drug Administration yesterday issued guidance for Covid-19 vaccine developers, requiring extended follow-up with clinical trial participants. . . . → Read More: FDA Bucks White House, Issues Strict Vaccine Guidance

Study Testing Wearables Data for Covid-19 Clues

Smart watch with PhysIQ app

A biomedical engineering lab and analytics company are testing the feasibility of algorithms to find early signs of Covid-19 symptoms from smart watch users. . . . → Read More: Study Testing Wearables Data for Covid-19 Clues

Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines

Syrine ingloved hand

In a joint statement today, CEOs of nine companies promised to follow the highest ethical and scientific standards in development and testing of their Covid-19 vaccines. . . . → Read More: Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines

NIH Nixes Convalescent Plasma Covid-19 Therapy

Donated plasma

An expert panel convened by National Institutes of Health says current data do not support recommending convalescent plasma as a treatment for Covid-19 infections. . . . → Read More: NIH Nixes Convalescent Plasma Covid-19 Therapy

Late-Stage Covid-19 Vaccine Trial Underway in U.S.

Covid-19 vaccine infographic

Global drug maker AstraZeneca is starting its late-stage Covid-19 vaccine clinical trial in the U.S., with a vow not to cut corners in its processes. . . . → Read More: Late-Stage Covid-19 Vaccine Trial Underway in U.S.

Food Allergy Biotech Acquired for $2.6B

Palforzia capsules

Aimmune Therapeutics Inc., a developer of food allergy drugs, was acquired today by global consumer products company Nestlé for $2.6 billion. . . . → Read More: Food Allergy Biotech Acquired for $2.6B

NIH Issues Contracts for Faster Covid-19 Diagnostics

Accula SARS-CoV-2 test

National Institutes of Health awarded contracts to seven companies for higher-speed Covid-19 detection tests to ease current reporting delays. . . . → Read More: NIH Issues Contracts for Faster Covid-19 Diagnostics

NIH Expands Covid-19 Test Technology Challenge

Covid-19 testing

National Institutes of Health is expanding its challenge competition to make tests for Covid-19 viruses more widely available and return results faster. . . . → Read More: NIH Expands Covid-19 Test Technology Challenge

Immune Responses Shown in Covid-19 Nasal Vaccine

Nasal spray

An experimental vaccine to prevent Covid-19 infections, given as a nasal spray, produces immune responses in tests with lab mice. . . . → Read More: Immune Responses Shown in Covid-19 Nasal Vaccine